Search Results - "Bevan, P."

Refine Results
  1. 1
  2. 2
  3. 3

    What an anesthesiologist should know about pediatric arrhythmias by Kuntz, Michael T., Eagle, Susan S., Dalal, Aarti, Samouil, Marc M., Staudt, Genevieve E., Londergan, Bevan P.

    Published in Pediatric anesthesia (01-12-2024)
    “…Identifying and treating pediatric arrhythmias is essential for pediatric anesthesiologists. Pediatric patients can present with narrow or wide complex…”
    Get full text
    Journal Article
  4. 4

    Insulin signalling by Bevan, P

    Published in Journal of cell science (01-04-2001)
    “…ABSTRACT Insulin binding to its receptor results in receptor autophosphorylation on tyrosine residues and the tyrosine phosphorylation of insulin receptor…”
    Get full text
    Journal Article
  5. 5

    Accounting for the Impact of Conservation on Human Well‐Being by MILNER‐GULLAND, E.J, MCGREGOR, J.A, AGARWALA, M, ATKINSON, G, BEVAN, P, CLEMENTS, T, DAW, T, HOMEWOOD, K, KUMPEL, N, LEWIS, J, MOURATO, S, PALMER FRY, B, REDSHAW, M, ROWCLIFFE, J.M, SUON, S, WALLACE, G, WASHINGTON, H, WILKIE, D

    Published in Conservation biology (01-10-2014)
    “…Conservationists are increasingly engaging with the concept of human well‐being to improve the design and evaluation of their interventions. Since the…”
    Get full text
    Journal Article
  6. 6

    Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer by Heinemann, V, Ebert, M P, Laubender, R P, Bevan, P, Mala, C, Boeck, S

    Published in British journal of cancer (05-03-2013)
    “…Background: To evaluate the efficacy and tolerability of the urokinase plasminogen activator (uPA) inhibitor upamostat in combination with gemcitabine in…”
    Get full text
    Journal Article
  7. 7

    Facilitating Collaboration in Rare Genetic Disorders Through Effective Matchmaking in DECIPHER by Chatzimichali, Eleni A., Brent, Simon, Hutton, Benjamin, Perrett, Daniel, Wright, Caroline F., Bevan, Andrew P., Hurles, Matthew E., Firth, Helen V., Swaminathan, Ganesh J.

    Published in Human mutation (01-10-2015)
    “…ABSTRACT DECIPHER (https://decipher.sanger.ac.uk) is a web‐based platform for secure deposition, analysis, and sharing of plausibly pathogenic genomic variants…”
    Get full text
    Journal Article
  8. 8

    Targeting of two aspects of metabolism in breast cancer treatment by Gang, Bevan P, Dilda, Pierre J, Hogg, Phillip J, Blackburn, Anneke C

    Published in Cancer biology & therapy (01-01-2014)
    “…Deregulated metabolism is gaining recognition as a hallmark of cancer cells, and is being explored for therapeutic potential. The Warburg effect is a metabolic…”
    Get full text
    Journal Article
  9. 9
  10. 10

    In vitro characterization of the subharmonic ultrasound signal from Definity microbubbles at high frequencies by Cheung, K, Couture, O, Bevan, P D, Cherin, E, Williams, R, Burns, P N, Foster, F S

    Published in Physics in medicine & biology (07-03-2008)
    “…Ultrasound microbubble contrast agents have been demonstrated to scatter subharmonic energy at one-half the driving frequency. At ultrasound frequencies in the…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Reduced metal ion concentrations in atherosclerotic plaques from subjects with Type 2 diabetes mellitus by Stadler, Nadina, Heeneman, Sylvia, Vöö, Stefan, Stanley, Naomi, Giles, Gregory I, Gang, Bevan P, Croft, Kevin D, Mori, Trevor A, Vacata, Vladimir, Daemen, Mat J.A.P, Waltenberger, Johannes, Davies, Michael J

    Published in Atherosclerosis (01-06-2012)
    “…Highlights ► Elevated levels of metal ions have been proposed as catalysts in atherosclerosis. ► Lesions from people with and without Type 2 diabetes were…”
    Get full text
    Journal Article
  13. 13

    The Molecular Design of S-Nitrosothiols as Photodynamic Agents for Controlled Nitric Oxide Release by Giles, Niroshini M., Kumari, Sweta, Gang, Bevan P., Yuen, Chun W. W., Billaud, Emilie M. F., Giles, Gregory I.

    Published in Chemical biology & drug design (01-09-2012)
    “…Nitric oxide is a small messenger molecule utilized by nature in cell signalling and the non‐specific immune response. At present, nitric oxide releasing…”
    Get full text
    Journal Article
  14. 14

    DECIPHER: web-based, community resource for clinical interpretation of rare variants in developmental disorders by SWAMINATHAN, Ganesh J, BRAGIN, Eugene, CHATZIMICHALI, Eleni A, CORPAS, Manuel, BEVAN, A. Paul, WRIGHT, Caroline F, CARTER, Nigel P, HURLES, Matthew E, FIRTH, Helen V

    Published in Human molecular genetics (15-10-2012)
    “…Patients with developmental disorders often harbour sub-microscopic deletions or duplications that lead to a disruption of normal gene expression or…”
    Get full text
    Journal Article
  15. 15

    DECIPHER: Supporting the interpretation and sharing of rare disease phenotype‐linked variant data to advance diagnosis and research by Foreman, Julia, Brent, Simon, Perrett, Daniel, Bevan, Andrew P., Hunt, Sarah E., Cunningham, Fiona, Hurles, Matthew E., Firth, Helen V.

    Published in Human mutation (01-06-2022)
    “…DECIPHER (https://www.deciphergenomics.org) is a free web platform for sharing anonymized phenotype‐linked variant data from rare disease patients. Its dynamic…”
    Get full text
    Journal Article
  16. 16

    Talocalcaneal Tarsal Coalitions and the Calcaneal Lengthening Osteotomy: The Role of Deformity Correction by Mosca, Vincent S, Bevan, Wesley P

    “…BACKGROUND:Surgical resection of persistently painful talocalcaneal tarsal coalitions may not reliably relieve symptoms in patients with large coalitions…”
    Get full text
    Journal Article
  17. 17

    Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics by POSNER, B. I, FAURE, R, SHAVER, A, BURGESS, J. W, BEVAN, A. P, LACHANCE, D, GUIYI ZHANG-SUN, FANTUS, I. G, NG, J. B, HALL, D. A, SOO LUM, B

    Published in The Journal of biological chemistry (11-02-1994)
    “…Twelve peroxovanadium (pV) compounds, each containing an oxo ligand, one or two peroxo anions, and an ancillary ligand in the inner coordination sphere of V,…”
    Get full text
    Journal Article
  18. 18

    Weight-Bearing in the Nonoperative Treatment of Acute Achilles Tendon Ruptures: A Randomized Controlled Trial by Young, Simon W, Patel, Alpesh, Zhu, Mark, van Dijck, Stephanie, McNair, Peter, Bevan, Wesley P, Tomlinson, Matthew

    “…BACKGROUND:The rate of Achilles tendon ruptures is increasing, but there is a lack of consensus on treatment of acute injuries. The purpose of this trial was…”
    Get full text
    Journal Article
  19. 19

    Weight-Bearing in the Nonoperative Treatment of Acute Achilles Tendon Ruptures by Young, Simon W, Patel, Alpesh, Zhu, Mark, van Dijck, Stephanie, McNair, Peter, Bevan, Wesley P, Tomlinson, Matthew

    “…Background:The rate of Achilles tendon ruptures is increasing, but there is a lack of consensus on treatment of acute injuries. The purpose of this trial was…”
    Get full text
    Journal Article
  20. 20

    Emergency First Responders and Professional Wellbeing: A Qualitative Systematic Review by Bevan, Malcolm P, Priest, Sally J, Plume, Ruth C, Wilson, Emma E

    “…Emergency first responders (EFRs) such as police officers, firefighters, paramedics and logistics personnel often suffer high turnover due to work-related…”
    Get full text
    Journal Article